Composition for treating sweat stain
A technology of composition and sweat spots, applied in the direction of drug combination, drug delivery, plant raw materials, etc., can solve problems such as inability to treat sweat spots
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] A medicine for treating sweat spots, which contains the following medicines in parts by weight, 20 parts of Jade Leaf Golden Flower, 40 parts of Mountain Silver Flower, 10 parts of Dracaena japonica, 40 parts of Trichosanthes, 50 parts of Hedyotis diffusa, 60 parts of Qingye and 20 parts of Litectin, all the above components were ground and pulverized, passed through a 80-120 mesh sieve, taken orally by the patient, twice a day, 10 grams each time, taken with warm water, 25 days as a course of treatment , Avoid spicy, spicy, greasy food, tobacco and alcohol during the medication.
Embodiment 2
[0014] The preparation and taking method of the medicine of this embodiment are the same as that of Example 1, the difference is: a kind of medicine for the treatment of sweat spots, containing the following medicines in parts by weight, 40 parts of Jade leaf golden flower, 20 parts of mountain silver flower, stegophyllum 20 parts of blood tree, 20 parts of trident bitterwood, 70 parts of Hedyotis diffusa, 40 parts of Daqingye, 40 parts of rock berberine.
Embodiment 3
[0016] The preparation and taking method of the medicine of this embodiment are the same as that of Example 1, the difference is that: a kind of medicine for the treatment of sweat spots contains the following medicines in parts by weight, 30 parts of Jade leaf golden flower, 30 parts of mountain silver flower, stegophyllum 15 parts of blood tree, 30 parts of trident bitterwood, 60 parts of Hedyotis diffusa, 50 parts of Daqingye, and 30 parts of rock berberine.
[0017] The statistical treatment is as follows:
[0018] 1. General information A total of 120 outpatients with sweat spots were collected from January 2015 to June 2016, aged 15-45 years, with a course of 1 month to 12 months. Randomly divided into: a treatment group of 60 cases, a control group of 60 cases. There was no significant difference in age, condition and other data between the two groups, and they were comparable.
[0019] 2. Diagnostic criteria According to the diagnostic criteria of the National Sympos...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com